Wallstent支架在非血栓性髂静脉病变治疗中的膨胀不足
该回顾性分析纳入203例非血栓性髂静脉病变患者共242次Wallstent支架治疗,未行球囊扩张,平均支架展开面积仅为预期支架面积的69.58%,多因素回归显示支架标称直径越大膨胀不足越显著,性别、年龄、侧别、狭窄位置及CEAP评分与膨胀不足无显著相关。
要点
- Wallstent治疗非血栓性髂静脉病变平均仅展开至预期支架面积的69.58%(范围23.87–123.35%)。
- 支架标称直径越大,膨胀不足程度越显著。
- 性别、年龄、支架侧别、狭窄位置及CEAP评分与支架膨胀不足无显著差异。
核心结论
- 较大的支架标称直径与更大程度的支架膨胀不足相关。
研究设计与样本
- 回顾性分析2012年12月至2016年1月间所有接受Wallstent支架治疗的非血栓性髂静脉病变患者,共203例(男64例、女139例,平均年龄68±13.9岁)行242次治疗,均未行支架置入前后球囊扩张。
主要发现
- 疾病严重程度按CEAP评分分布:C1(0例)、C2(0例)、C3(59例,24%)、C4(148例,61%)、C5(4例,2%)、C6(31例,13%)。
- 支架平均展开至预期支架面积的69.58%(范围23.87–123.35%)。
- 多因素线性回归显示支架标称直径与达到的预期支架面积呈显著负相关,基于标称直径的回归系数为:16 mm(−15.0,P=0.1519)、18 mm(−21.0,P=0.0077)、20 mm(−23.2,P=0.0059)、20–22 mm(−35.3,P<0.0001)。
- 基于性别、年龄、支架侧别、狭窄位置或CEAP评分,未检测到支架膨胀不足的显著差异。
临床怎么用
- 作者认为这些发现可能对未来静脉支架设计有启示。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Iliac vein stenting is increasingly being used in the treatment of chronic venous insufficiency caused by nonthrombotic iliac vein lesions (NIVL). We have noticed that many stents do not deploy to the expected stent area (ESA) as designated by the manufactured stent diameter (MSD). The purpose of this study was to identify factors predictive of Wallstent® underexpansion in the iliocaval venous system. METHODS: Retrospective analysis of all patients with NIVL who were treated with iliac vein stenting using Wallstents® was performed. None of the patients in this study underwent pre-or post-stenting balloon angioplasty. Multiway analysis of variance and multiple linear regression analysis were performed to examine the effects of gender, age, stent laterality, location of stenosis, and CEAP (clinical, etiology, anatomy, and pathophysiology) score at presentation on the proportion of observed stent area (OSA) to ESA. RESULTS: Two-hundred three patients (64 male and 139 female; mean age: 68 ± 13.9 years) underwent 242 treatments between December 2012 and January 2016. Disease severity based on CEAP score were: C1 (0), C2 (0), C3 (n = 59, 24%), C4 (n = 148, 61%), C5 (n = 4, 2%), and C6 (n = 31, 13%). On average, stents deployed to 69.58% of the ESA (range, 23.87–123.35%). Multiple linear regression analysis showed a significant negative correlation between increasing MSD and ESA achieved. Regression coefficients for differences in percent difference between ESA and OSA based on MSD were as follows: 16 mm (−15.0, P = 0.1519), 18 mm (−21.0, P = 0.0077), 20 mm (−23.2, P = 0.0059), and 20–22 mm (−35.3, P < 0.0001). No significant difference in stent underexpansion was detected based on gender, age, stent laterality, location of stenosis, or CEAP score. CONCLUSIONS: Larger MSD is associated with greater magnitude of stent underexpansion. These findings may have implications for future venous stent designing.
引用
- Mandel JE, Ostrozhynskyy Y, Hingorani A, et al. Underexpansion of Wallstents® in the Treatment of Nonthrombotic Iliac Vein Lesions. Ann Vasc Surg. 2018. PMID: 29777843. doi:10.1016/j.avsg.2018.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。